What is Spravato?
Spravato is a new antidepressant medication (intranasal esketamine) indicated for treating treatment-resistant depression, taken in conjunction with an oral antidepressant. It is administered at Paramount Health Directions under professional supervision as an intranasal medication. Administration sessions last up to two and a half hours to monitor tolerability of the medication.
How Does Spravato Work?
Spravato targets the N-methyl-d-aspartate (NMDA) receptor, and it is believed to work differently than currently available oral antidepressants. This believed mechanism of action allows access to new brain pathways and a better response to medications patients are either currently taking or add on at the time of treatment.
Want to Learn More?
For more specifics on Spravato, please visit their website here.
For more information about starting Spravato at Paramount Health Directions, or to see if Spravato may be the answer for you, please call 303-393-1726 to speak with our Spravato Coordinator.
